Pioglitazone + Metformin

Published 17 April 2015, updated 29 July 2016

dm+d

418835009

Medicine Compliance Aid Stability

Manufacturer

Takeda UK Ltd

Trade Name

Competact

Formulation

Tablets 15mg/850mg

Recommendation

A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.

Recommendation Notes

Protect from light

Protect from moisture

Theoretical Concerns

Protect from moisture and humidity. Protect from light.

Review Date

23 January 2015

MCA Overview